Unknown

Dataset Information

Prevalence and health care costs of mitochondrial disease in Ontario, Canada: A population-based cohort study.


ABSTRACT:

Background

Mitochondrial disease prevalence has been estimated at 1 in 4000 in the United States, and 1 in 5000 worldwide. Prevalence in Canada has not been established, though multi-linked health administrative data resources present a unique opportunity to establish robust population-based estimates in a single-payer health system. This study used administrative data for the Ontario, Canada population between April 1988 and March 2019 to measure mitochondrial disease prevalence and describe patient characteristics and health care costs.

Results

3069 unique individuals were hospitalized with mitochondrial disease in Ontario and eligible for the study cohort, representing a period prevalence of 2.51 per 10,000 or 1 in 3989. First hospitalization was most common between ages

SUBMITTER: Buajitti E 

PROVIDER: S-EPMC8993002 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature